Abstract: Rapid antimicrobial susceptibility testing (AST) would decrease misuse and overuse of antibiotics.T he "holy grail" of AST is aphenotype-based test that can be performed within ad octor visit. Such at est requires the ability to determine ap athogens susceptibility after only as hort antibiotic exposure.Herein, digital PCR (dPCR) was employed to test whether measuring DNAreplication of the target pathogen through digital single-molecule counting would shorten the required time of antibiotic exposure.P artitioning bacterial chromosomal DNAi nto many small volumes during dPCR enabled AST results after short exposure times by 1) precise quantification and 2) am easurement of how antibiotics affect the states of macromolecular assembly of bacterial chromosomes.T his digital AST (dAST) determined susceptibility of clinical isolates from urinary tract infections (UTIs) after 15 min of exposure for all four antibiotic classes relevant to UTIs.This work lays the foundation to develop arapid, pointof-care AST and strengthen global antibiotic stewardship.
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The increasingly liberal use and misuse of antibiotics (ABX) has led to widespread development of antibiotic resistance. [1] To address this crisis,w en eed rapid and reliable tests of ap athogens susceptibility to the drugs available (antimicrobial susceptibility test (AST)) that enable healthcare providers to administer correct, life-saving treatments,i nt urn facilitating antibiotic stewardship [2] and drastically decreasing hospital costs. [1a,3] Having ar apid AST that provides results within the period of ad octor visit would improve patient outcomes and reduce the spread of antibiotic resistance. [4] The development of such atest is currently the focus of significant research efforts [5] that aim to supplant traditional clinical methods.T or educe the spread of resistance,o ne urgently needed AST is for urinary tract infections (UTIs), which are among the most common bacterial infections,yet can progress to pyelonephritis or sepsis. [6] Tw otypes of ASTs are currently used in clinical settings: traditional culture-based methods and genotypic methods. Culture-based tests remain the gold standard for determining antibiotic susceptibility because they detect phenotypic susceptibility to ad rug. However,t hese tests require al ong period of antibiotic exposure (typically 16-24 h). [7] We [8] and others [5a,b,k, 9] have proposed using confinement of single,o r asmall number of,bacterial cells in small volumes to reduce the duration of antibiotic exposure required to read out the phenotype of the target pathogen. However,t hese methods typically do not differentiate between the pathogen and potential contamination of the sample with commensal bacteria. Alternative genotypic methods (detecting genes responsible for known mechanisms of resistance) are more rapid than culture-based approaches.
[10] However,t hese resistance genes constitute only af raction of all possible mechanisms of resistance, [11] and new forms of resistance evolve quickly. [12] Therefore,p redicting resistance by analyzing afew known resistance genes is not ageneral solution. [13] To develop more rapid and specific phenotypic tests, hybrid approaches have been proposed that use quantification of nucleic acids to determine the susceptibility or resistance phenotype after as hort antibiotic exposure. These tests do not rely on detecting specific resistance genes.
[5g,i] Fore xample,q uantification of RNAh as allowed determination of susceptibility to ciprofloxacin (cip) and rifampin, [5i] which impair transcription, after exposure times as short as 15 min. However,t hese methods require longer incubation times when using antibiotics with different mechanisms of action. Although quantitative PCR (qPCR) has been used to quantify DNAafter 2-9 hofantibiotic exposure, and thus can detect bacterial growth and determine susceptibility, [5d,e] an ideal exposure time would be shorter than one cell division.
Herein we tested the hypothesis that digital methods of nucleic acid quantification, [14] such as digital PCR (dPCR), would enable use of DNAm arkers to perform ap henotypic AST after short antibiotic exposure.Digital methods partition bacterial chromosomal DNAinto thousands of compartments and then use targeted amplification to determine the number of "positive" compartments containing DNAcarrying one or more copies of the target gene.T his partitioning should enable more precise and robust measurements of concentrations of bacterial DNA, achieving higher statistical power with fewer replicates relative to qPCR. [14c, 15] Further,w e hypothesized that this partitioning would provide unique capabilities for AST when analyzing target genes present in amacromolecular assembly,s uch as ab acterial chromosome during replication. In contrast to qPCR, dPCR results should reflect the state of the macromolecular assembly,p roviding ad ifferent count for ap air of segregated chromosomes (two positives) versus the chromosomal assembly just prior to segregation (one positive). We tested our hypotheses in the context of four of the main antibiotics used in UTI treatment: ciprofloxacin (cip), nitrofurantoin (nit), sulfamethoxazole/ trimethoprim (sxt), and amoxicillin/clavulanic acid (amc).
[6a, 7b, 16] We first determined the minimum antibiotic exposure time necessary to differentiate susceptible and resistant clinical UTI isolates using qPCR analysis of DNAa fter incubation in the presence ("treated") or absence ("control") of antibiotics (see the Supporting Information). Cycle thresholds were used to calculate the relative fold change in DNA concentration compared to t = 0min (Figure 1 ). When treated with cip,D NA replication in susceptible isolates was significantly inhibited, resulting in an increasing difference in fold change between target concentrations in treated and control samples.I ft he isolate was resistant, DNAr eplication continued regardless of exposure.T oa lign with US Food and Drug Administration (FDA) requirements for very major errors, [17] we used ac onservative alpha, 0.02 (see the Supporting Information). Under these parameters,s usceptibility to cip could be determined after 15 min of exposure.We obtained similar results using isolates precultured in media and in urine (see Figure S1 in the Supporting Information), and chose to conduct all subsequent experiments in media to decrease the work with human samples and to ensure reproducibility. These results provide the first evidence of detection of phenotypic susceptibility based on DNAq uantification after only 15 min of antibiotic exposure.T he rapid effect of cip on DNAr eplication is logical because the drugs mechanism of action is to inhibit DNA-gyrase and topoisomerase IV, producing double stranded breaks in DNAa nd directly inhibiting DNAr eplication. [18] To test generality,w ee valuated AST with three other antibiotics:nit, [19] sxt, [20] and amc (amc and other b-lactam antibiotics are not known to specifically affect DNAr eplication;s ee the Supporting Information). Using qPCR, 15 min of exposure to these three antibiotics was not sufficient to detect as ignificant difference in DNAr eplication in susceptible isolates (Figure 2B-D) , whereas statistically significant differences were detectable after cip treatment (Figure 2A) .
Af ocus of this work was to evaluate the differences in minimum antibiotic exposure time necessary to determine susceptibility when quantification of changes in DNAi s performed with qPCR versus dPCR. Thus,w en ext tested AST with digital quantification by quantifying the same DNA samples from the qPCR analysis using dPCR (Figure 3 ). For cip,w ed etected am ore statistically significant difference (smaller p value than in qPCR) between target concentrations in treated and control susceptible isolates ( Figure 3A) , whereas target concentrations did not differ between treated and control resistant isolates ( Figure 3B ). As ignificant difference was also detected after 15 min exposures to nit ( Figure 3C )o rsxt ( Figure 3C) . Interestingly,n either qPCR nor dPCR detected susceptibility after exposure to amc when samples were denatured and treated with protease during extraction ( Figure S2 ). This confirmed that genome replication proceeded (resulting in an increase in the total number of amplifiable targets) during incubation with amc regardless of phenotype.W et herefore tested the hypothesis that dPCR would be sensitive not only to the total gene copy number, but also to the state of macromolecular assembly of chromosomal DNA. If exposure to amc causes changes in chromosome segregation, even without affecting replication, dPCR should still be able to differentiate susceptible and resistant phenotypes.T op reserve chromosome structure and macromolecular complexes, we performed DNAe xtraction under nondenaturing condi- tions without protease treatment. Under these conditions, dPCR provided the susceptibility phenotype after 15 min of exposure to amc ( Figure 3D ).
To test whether dPCR differentiated susceptible and resistant isolates by quantifying macromolecular assemblies, we designed control experiments in which all assemblies were sheared into about 1000 bp DNAf ragments,m uch smaller than the average distance between 23S genes within the genome (see the Supporting Information). As expected, shearing caused an increase in measured target concentration when quantified using dPCR, but not using qPCR (Figure 4A,B) . In samples that were not sheared, dPCR detected the susceptible phenotype after 15 min of amc exposure ( Figure 4C ). Shearing these samples to disrupt macromolecular assemblies eliminated the ability to detect susceptibility ( Figure 4D) ; qPCR measurements confirmed this was not due to loss of DNA. This suggests that in amc-susceptible isolates short exposure to amc does not result in ac hange of the total number of target gene copies,b ut does change the macromolecular assembly of these copies.
Our results suggest apreviously unknown effect of brief blactam antibiotic exposure:adelay in chromosome segregation. Using dPCR (but not qPCR) this effect can be quantified by counting the number of macromolecular DNA assemblies containing 23S target genes,and used for AST.The high resolution of digital quantification enables measuring small (less than two-fold) changes in chromosome replication and segregation after an antibiotic exposure shorter than the average time of cell division. ThedAST approach developed here adds chromosome segregation to the list of the phenotypic markers suitable for rapid antibiotic susceptibility detection. Theability to partition macromolecular assemblies allows dAST to be used even when genome replication proceeds on the timescale of antibiotic exposure,w hile the high precision of digital quantification allows accurate determination of susceptibility after shorter exposure times than would be required using less-precise methods such as qPCR.
These dAST results warrant afollow-up study with awide range of Gram-positive and Gram-negative bacterial isolates from urine,blood, and other sample types,and then aclinical study comparing dAST directly from patient samples to the gold standard culture-based methods.E lucidating the effects of using variable clinical samples with arange of background matrices is acritical next step in the development of arapid, sample-to-answer AST.U ltimately,asample-to-answer AST at the point of care must be robust and rapid and should require minimal sample handling and instrumentation. Ideally,s uch aw orkflow will integrate sample handling, antibiotic exposure,a nd quantification into as ingle device.W e anticipate that digital isothermal amplification chemistries will replace dPCR in dAST. [15a, 21] When integrated with sample preparation [22] and combined with simple readouts, [23] we envision that digital quantification will establish an ew paradigm in rapid point of care AST.
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